Search research articles
Contact Us
Filters
Showing results (131-140 of 272) with videos related to
Page
of 28
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 20, 2004
Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes
Jinjuan Wang, Oliver W Press, Catherine G Lindgren, et al.
Bioconjugate Chemistry
|
May 16, 2002
A streptavidin-biotin binding system that minimizes blocking by endogenous biotin
Kevin J Hamblett, Brian B Kegley, Don K Hamlin, et al.
Nuclear Medicine Communications
|
July 31, 2014
90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution
Manuela Matesan, Joseph Rajendran, Oliver W Press, et al.
Molecular Pharmaceutics
|
October 19, 2012
Intracellular delivery and trafficking dynamics of a lymphoma-targeting antibody-polymer conjugate
Geoffrey Y Berguig, Anthony J Convertine, Julie Shi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 2, 2011
Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells
Maria C Palanca-Wessels, Anthony J Convertine, Richelle Cutler-Strom, et al.
Leukemia & Lymphoma
|
December 8, 2010
Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop
Michael E Williams, Joseph M Connors, Martin H Dreyling, et al.
Bone Marrow Transplantation
|
April 25, 2001
Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older
A K Gopal, T A Gooley, J B Golden, et al.
Blood
|
November 26, 2002
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas
John M Pagel, Nathan Hedin, Krishnan Subbiah, et al.
Oncotarget
|
February 4, 2016
Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells
Maria C Palanca-Wessels, Garrett C Booth, Anthony J Convertine, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 6, 2008
Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane
Scott E James, Philip D Greenberg, Michael C Jensen, et al.
Page
of 28
Search research articles
Search
Showing results (131-140 of 272) with videos related to
Sort By:
Page
of 28
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 20, 2004
Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes
Jinjuan Wang, Oliver W Press, Catherine G Lindgren, et al.
Bioconjugate Chemistry
|
May 16, 2002
A streptavidin-biotin binding system that minimizes blocking by endogenous biotin
Kevin J Hamblett, Brian B Kegley, Don K Hamlin, et al.
Nuclear Medicine Communications
|
July 31, 2014
90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution
Manuela Matesan, Joseph Rajendran, Oliver W Press, et al.
Molecular Pharmaceutics
|
October 19, 2012
Intracellular delivery and trafficking dynamics of a lymphoma-targeting antibody-polymer conjugate
Geoffrey Y Berguig, Anthony J Convertine, Julie Shi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 2, 2011
Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells
Maria C Palanca-Wessels, Anthony J Convertine, Richelle Cutler-Strom, et al.
Leukemia & Lymphoma
|
December 8, 2010
Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop
Michael E Williams, Joseph M Connors, Martin H Dreyling, et al.
Bone Marrow Transplantation
|
April 25, 2001
Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older
A K Gopal, T A Gooley, J B Golden, et al.
Blood
|
November 26, 2002
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas
John M Pagel, Nathan Hedin, Krishnan Subbiah, et al.
Oncotarget
|
February 4, 2016
Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells
Maria C Palanca-Wessels, Garrett C Booth, Anthony J Convertine, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 6, 2008
Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane
Scott E James, Philip D Greenberg, Michael C Jensen, et al.
Page
of 28